Underwriter | Biotechnology |
Date |
Offering |
7/16/04 |
Offering |
After-Market |
|
|
|
|
|
|
|
Adams, Harkness |
Acadia |
5/26/04 |
$7 |
$6.30 |
$35 |
-10% |
|
Ariad |
3/24/04 |
$8.50 |
$5.40 |
$43 |
-36% |
|
Immunicon Corp. |
4/15/04 |
$8 |
$8.15 |
$55.2 |
+2% |
|
Isolagen |
6/10/04 |
$8.50 |
$9.14 |
$61.2 |
+8% |
A.G. Edwards |
Vasogen Inc. |
2/27/04 |
$5.90 |
$4.50 |
$57.7 |
-24% |
Banc of America |
Acadia |
5/26/04 |
$7 |
$6.30 |
$35 |
-10% |
|
Alnylam Pharmaceuticals |
5/27/04 |
$6 |
$7 |
$34.5 |
+17% |
|
Barrier Therapeutics |
4/29/04 |
$15 |
$13.53 |
$75 |
-10% |
|
Memory Pharmaceuticals |
4/5/04 |
$7 |
$8.01 |
$40.25 |
+14% |
|
Momenta |
6/21/04 |
$6.50 |
$8.53 |
$40 |
+31% |
|
Seattle Genetics |
2/5/04 |
$8.25 |
$5.60 |
$66.4 |
-32% |
Bear, Stearns |
Bone Care |
5/13/04 |
$21.75 |
$25.05 |
$97.9 |
+15% |
|
Bruker BioSciences |
4/23/04 |
$4.50 |
$4.15 |
$15.5 |
-8% |
|
Dynavax |
2/18/04 |
$7.50 |
$5.50 |
$51.75 |
-27% |
|
Eyetech |
1/29/04 |
$21 |
$40.10 |
$156.98 |
+91% |
|
Pharmion Corp. |
7/1/04 |
$48 |
$42.58 |
$253.9 |
-11% |
Brean Murray |
Genitope Corp. |
5/27/04 |
$8.50 |
$9.91 |
$59.5 |
+17% |
C.E. Unterberg, |
Cepheid Inc. |
2/12/04 |
$11.25 |
$9.95 |
$61.88 |
-12% |
CIBC World |
Corgentech Inc. |
2/12/04 |
$16 |
$15.80 |
$96 |
-1% |
|
Critical |
5/27/04 |
$7 |
$6.94 |
$42 |
-1% |
|
Cypress Bioscience |
4/2/04 |
$11.50 |
$11.51 |
$79.35 |
+0% |
|
Guilford |
7/1/04 |
$4.50 |
$4.53 |
$45 |
+1% |
|
Isolagen Inc. |
6/10/04 |
$8.50 |
$9.14 |
$61.2 |
+8% |
|
Momenta |
6/21/04 |
$6.50 |
$8.53 |
$40 |
+31% |
|
Nuvelo Inc. |
3/3/04 |
$13 |
$8.55 |
$74.75 |
-34% |
|
Renovis Inc. |
2/5/04 |
$12 |
$8.60 |
$66 |
-28% |
|
Seattle Genetics |
2/5/04 |
$8.25 |
$5.60 |
$66.4 |
-32% |
|
Xenogen Corp. |
7/16/04 |
$7 |
$7.50 |
$29.4 |
+7% |
Citigroup Global |
Alnylam |
5/27/04 |
$6 |
$7 |
$34.5 |
+17% |
|
Bone Care |
5/13/04 |
$21.75 |
$25.05 |
$97.9 |
+15% |
|
Guilford |
7/1/04 |
$4.50 |
$4.53 |
$45 |
+1% |
|
Martek |
2/4/03 |
$65.59 |
$50.75 |
$11.6 |
-23 |
|
Senomyx Inc. |
6/21/04 |
$6 |
$6.20 |
$36 |
+3% |
Credit Suisse |
Corgentech Inc. |
2/12/04 |
$16 |
$15.80 |
$96 |
-1% |
|
Cytokinetics Inc. |
4/29/04 |
$13 |
$12.94 |
$103.2 |
-0% |
|
Eyetech |
1/29/04 |
$21 |
$40.10 |
$156.98 |
+91% |
|
Rigel |
2/6/04 |
$20 |
$11.70 |
$62.7 |
-42% |
Deutsche Bank |
Cypress Bioscience |
4/2/04 |
$11.50 |
$11.51 |
$79.35 |
+0% |
|
Dynavax |
2/18/04 |
$7.50 |
$5.50 |
$51.75 |
-27% |
|
IntraBiotics |
5/5/04 |
$13 |
$3.61 |
$44.9 |
-72% |
|
Metabasis |
6/16/04 |
$7 |
$6.50 |
$35 |
-7% |
|
Senomyx Inc. |
6/21/04 |
$6 |
$6.20 |
$36 |
+3% |
First Albany |
Bone Care |
5/13/04 |
$21.75 |
$25.05 |
$97.9 |
+15% |
|
NeoPharm Inc. |
1/22/04 |
$18.25 |
$7.78 |
$78.69 |
-57% |
|
Senomyx Inc. |
6/21/04 |
$6 |
$6.20 |
$36 |
+3% |
Fortis Securities |
Memory |
4/5/04 |
$7 |
$8.01 |
$40.25 |
+14% |
|
Rigel |
2/6/04 |
$20 |
$11.70 |
$62.7 |
-42% |
Goldman, Sachs |
Cytokinetics Inc. |
4/29/04 |
$13 |
$12.94 |
$103.2 |
-0% |
|
GTx Inc. |
2/3/04 |
$14.50 |
$9.04 |
$78.3 |
-38% |
|
Renovis Inc. |
2/5/04 |
$12 |
$8.60 |
$66 |
-28% |
Harris Nesbitt |
Aphton Corp. |
2/27/04 |
$6.50 |
$3.19 |
$52.3 |
-51% |
|
Inhibitex Inc. |
6/3/04 |
$7 |
$6.92 |
$38.7 |
-1% |
|
Tercica Inc. |
3/16/04 |
$9 |
$9.32 |
$56.93 |
+4% |
Jefferies & Co. |
Cypress Bioscience |
4/2/04 |
$11.50 |
$11.51 |
$79.35 |
+0% |
JMP Securities |
Acadia |
5/26/04 |
$7 |
$6.30 |
$35 |
-10% |
|
Ariad |
3/24/04 |
$8.50 |
$5.40 |
$43 |
-36% |
|
NeoPharm Inc. |
1/22/04 |
$18.25 |
$7.78 |
$78.69 |
-57% |
|
Nuvelo Inc. |
3/3/04 |
$13 |
$8.55 |
$74.75 |
-34% |
|
Xcyte Therapies |
3/16/04 |
$8 |
$4.60 |
$33.6 |
-43% |
|
Xenogen Corp. |
7/16/04 |
$7 |
$7.50 |
$29.4 |
+7% |
JP Morgan |
Barrier Therapeutics |
4/29/04 |
$15 |
$13.53 |
$75 |
-10% |
|
Cell Genesys |
3/17/04 |
$12.50 |
$8.65 |
$61.1 |
-31% |
|
Oscient |
2/6/04 |
$5.25 |
$4.10 |
$88.2 |
-22% |
|
Pharmion Corp. |
7/1/04 |
$48 |
$42.58 |
$253.9 |
-11% |
Lazard Freres |
Ariad |
3/24/04 |
$8.50 |
$5.40 |
$43 |
-36% |
|
Cypress Bioscience |
4/2/04 |
$11.50 |
$11.51 |
$79.35 |
+0% |
|
Cytokinetics Inc. |
4/29/04 |
$13 |
$12.94 |
$103.2 |
-0% |
|
Dendreon Corp. |
1/27/04 |
$12.75 |
$10.04 |
$150 |
-21% |
|
GTx Inc. |
2/3/04 |
$14.50 |
$9.04 |
$78.3 |
-38% |
|
Inhibitex Inc. |
6/3/04 |
$7 |
$6.92 |
$38.7 |
-1% |
|
IntraBiotics |
5/5/04 |
$13 |
$3.61 |
$44.9 |
-72% |
Leerink Swann |
Critical |
5/27/04 |
$7 |
$6.94 |
$42 |
-1% |
|
Exact Sciences |
2/5/04 |
$6.75 |
$5.65 |
$46.58 |
-16% |
|
Onyx |
2/3/04 |
$33.75 |
$37.12 |
$156.5 |
+10% |
Legg Mason Wood |
Anadys |
3/25/04 |
$7 |
$6.62 |
$48.96 |
-5% |
|
Corcept |
4/14/04 |
$12 |
$5.95 |
$54 |
-50% |
|
Immunicon Corp. |
4/15/04 |
$8 |
$8.15 |
$55.2 |
+2% |
|
Isolagen Inc. |
6/10/04 |
$8.50 |
$9.14 |
$61.2 |
+8% |
|
Metabasis |
6/16/04 |
$7 |
$6.50 |
$35 |
-7% |
|
Oscient |
2/6/04 |
$5.25 |
$4.10 |
$88.2 |
-22% |
Lehman Brothers |
Ariad |
3/24/04 |
$8.50 |
$5.40 |
$43 |
-36% |
|
Cell Genesys |
3/17/04 |
$12.50 |
$8.65 |
$61.1 |
-31% |
|
Corgentech Inc. |
2/12/04 |
$16 |
$15.80 |
$96 |
-1% |
|
Tercica Inc. |
3/16/04 |
$9 |
$9.32 |
$56.93 |
+4% |
Merrill Lynch |
Exact Sciences |
2/5/04 |
$6.75 |
$5.65 |
$46.58 |
-16% |
|
Eyetech |
1/29/04 |
$21 |
$40.10 |
$156.98 |
+91% |
Merriman Curhan |
Discovery Partners |
5/6/04 |
$5 |
$5.20 |
$41.53 |
+4% |
Morgan Stanley |
Barrier Therapeutics |
4/29/04 |
$15 |
$13.53 |
$75 |
-10% |
|
Eyetech |
1/29/04 |
$21 |
$40.10 |
$156.98 |
+91% |
|
Onyx |
2/3/04 |
$33.75 |
$37.12 |
$156.5 |
+10% |
|
Pharmion Corp. |
7/1/04 |
$48 |
$42.58 |
$253.9 |
-11% |
Needham & Co. |
Anadys |
3/25/04 |
$7 |
$6.62 |
$48.96 |
-5% |
|
Antigenics Inc. |
2/3/04 |
$10.50 |
$7.77 |
$56.7 |
-21% |
|
Cell Genesys |
3/17/04 |
$12.50 |
$8.65 |
$61.1 |
-31% |
|
Dendreon Corp. |
1/27/04 |
$12.75 |
$10.04 |
$150 |
-21% |
|
Nuvelo Inc. |
3/3/04 |
$13 |
$8.55 |
$74.75 |
-34% |
|
Rigel |
2/6/04 |
$20 |
$11.70 |
$62.7 |
-42% |
|
Senomyx Inc. |
6/21/04 |
$6 |
$6.20 |
$36 |
+3% |
|
Vasogen Inc. |
2/27/04 |
$5.90 |
$4.50 |
$57.7 |
-24% |
Pacific Growth |
Cytokinetics Inc. |
4/29/04 |
$13 |
$12.94 |
$103.2 |
-0% |
|
Pharmacyclics |
4/2/04 |
$13 |
$8.25 |
$41.6 |
-37% |
|
Pharmion Corp. |
7/1/04 |
$48 |
$42.58 |
$253.9 |
-11% |
Piper Jaffray |
Acadia |
5/26/04 |
$7 |
$6.30 |
$35 |
-10% |
|
Alnylam |
5/27/04 |
$6 |
$7 |
$34.5 |
+17% |
|
Anadys |
3/25/04 |
$7 |
$6.62 |
$48.96 |
-5% |
|
Corcept |
4/14/04 |
$12 |
$5.95 |
$54 |
-50% |
|
Corgentech Inc. |
2/12/04 |
$16 |
$15.80 |
$96 |
-1% |
|
Critical |
5/27/04 |
$7 |
$6.94 |
$42 |
-1% |
|
Dendreon Corp. |
1/27/04 |
$12.75 |
$10.04 |
$150 |
-21% |
|
Dynavax |
2/18/04 |
$7.50 |
$5.50 |
$51.75 |
-27% |
|
IntraBiotics |
5/5/04 |
$13 |
$3.61 |
$44.9 |
-72% |
|
Onyx |
2/3/04 |
$33.75 |
$37.12 |
$156.5 |
+10% |
|
Renovis Inc. |
2/5/04 |
$12 |
$8.60 |
$66 |
-28% |
|
Xcyte Therapies |
3/16/04 |
$8 |
$4.60 |
$33.6 |
-43% |
Punk, Ziegel |
Genitope Corp. |
5/27/04 |
$8.50 |
$9.91 |
$59.5 |
+17% |
RBC Capital |
Santarus Inc. |
4/1/04 |
$9 |
$12.57 |
$62.1 |
+40% |
|
Vasogen Inc. |
2/27/04 |
$5.90 |
$4.50 |
$57.7 |
-24% |
|
Xcyte Therapies |
3/16/04 |
$8 |
$4.60 |
$33.6 |
-43% |
Robert W. Baird |
Bone Care |
5/13/04 |
$21.75 |
$25.05 |
$97.9 |
+15% |
|
NeoPharm Inc. |
1/22/04 |
$18.25 |
$7.78 |
$78.69 |
-57% |
Tercica Inc. |
3/16/04 |
$9 |
$9.32 |
$56.93 |
+4% |
|
Rodman & |
Ariad |
3/24/04 |
$8.50 |
$5.40 |
$43 |
-36% |
|
Cepheid Inc. |
2/12/04 |
$11.25 |
$9.95 |
$61.88 |
-12% |
Roth Capital |
Bone Care |
5/13/04 |
$21.75 |
$25.05 |
$97.9 |
+15% |
|
Discovery Partners |
5/6/04 |
$5 |
$5.20 |
$41.53 |
+4% |
|
Targeted Genetics |
2/2/04 |
$2.35 |
$1.31 |
$25.5 |
-44% |
Ryan Beck & Co. |
Antigenics Inc. |
2/3/04 |
$10.50 |
$7.77 |
$56.7 |
-21% |
SG Cowen |
Anadys |
3/25/04 |
$7 |
$6.62 |
$48.96 |
-5% |
|
Bruker BioSciences |
4/23/04 |
$4.50 |
$4.15 |
$15.5 |
-8% |
|
Cell Genesys |
3/17/04 |
$12.50 |
$8.65 |
$61.1 |
-31% |
|
Critical |
5/27/04 |
$7 |
$6.94 |
$42 |
-1% |
|
Discovery Partners |
5/6/04 |
$5 |
$5.20 |
$41.53 |
+4% |
|
GTx Inc. |
2/3/04 |
$14.50 |
$9.04 |
$78.3 |
-38% |
|
Immunicon Corp. |
4/15/04 |
$8 |
$8.15 |
$55.2 |
+2% |
|
Metabasis |
6/16/04 |
$7 |
$6.50 |
$35 |
-7% |
|
Memory |
4/5/04 |
$7 |
$8.01 |
$40.25 |
+14% |
|
Momenta |
6/21/04 |
$6.50 |
$8.53 |
$40 |
+31% |
|
Onyx |
2/3/04 |
$33.75 |
$37.12 |
$156.5 |
+10% |
|
Renovis Inc. |
2/5/04 |
$12 |
$8.60 |
$66 |
-28% |
|
Santarus Inc. |
4/1/04 |
$9 |
$12.57 |
$62.1 |
+40% |
|
Targeted Genetics |
2/2/04 |
$2.35 |
$1.31 |
$25.5 |
-44% |
|
Tercica Inc. |
3/16/04 |
$9 |
$9.32 |
$56.93 |
+4% |
Stanford Group |
Genitope Corp. |
5/27/04 |
$8.50 |
$9.91 |
$59.5 |
+17% |
ThinkEquity |
Alnylam |
5/27/04 |
$6 |
$7 |
$34.5 |
+17% |
|
Momenta |
6/21/04 |
$6.50 |
$8.53 |
$40 |
+31% |
Thomas Weisel |
Corcept |
4/14/04 |
$12 |
$5.95 |
$54 |
-50% |
|
Exact Sciences |
2/5/04 |
$6.75 |
$5.65 |
$46.58 |
-16% |
|
Inhibitex Inc. |
6/3/04 |
$7 |
$6.92 |
$38.7 |
-1% |
|
Metabasis |
6/16/04 |
$7 |
$6.50 |
$35 |
-7% |
|
Rigel |
2/6/04 |
$20 |
$11.70 |
$62.7 |
-42% |
|
Santarus Inc. |
4/1/04 |
$9 |
$12.57 |
$62.1 |
+40% |
|
Xenogen Corp. |
7/16/04 |
$7 |
$7.50 |
$29.4 |
+7% |
UBS Investment |
Antigenics Inc. |
2/3/04 |
$10.50 |
$7.77 |
$56.7 |
-21% |
|
Aphton Corp. |
2/27/04 |
$6.50 |
$3.19 |
$52.3 |
-51% |
|
Bruker BioSciences |
4/23/04 |
$4.50 |
$4.15 |
$15.5 |
-8% |
|
Cepheid Inc. |
2/12/04 |
$11.25 |
$9.95 |
$61.88 |
-12% |
|
Dendreon Corp. |
1/27/04 |
$12.75 |
$10.04 |
$150 |
-21% |
|
Exact Sciences |
2/5/04 |
$6.75 |
$5.65 |
$46.58 |
-16% |
|
Guilford |
7/1/04 |
$4.50 |
$4.53 |
$45 |
+1% |
|
Immunicon Corp. |
4/15/04 |
$8 |
$8.15 |
$55.2 |
+2% |
|
Memory |
4/5/04 |
$7 |
$8.01 |
$40.25 |
+14% |
|
NeoPharm Inc. |
1/22/04 |
$18.25 |
$7.78 |
$78.69 |
-57% |
|
Nuvelo Inc. |
3/3/04 |
$13 |
$8.55 |
$74.75 |
-34% |
|
Santarus Inc. |
4/1/04 |
$9 |
$12.57 |
$62.1 |
+40% |
Wells Fargo Securities |
Xcyte Therapies |
3/16/04 |
$8 |
$4.60 |
$33.6 |
-43% |
William Blair |
Cepheid Inc. |
2/12/04 |
$11.25 |
$9.95 |
$61.88 |
-12% |
WR Hambrecht |
Genitope Corp. |
5/27/04 |
$8.50 |
$9.91 |
$59.5 |
+17% |
|
Seattle Genetics |
2/5/04 |
$8.25 |
$5.60 |
$66.4 |
-32% |
Notes: | ||||||
* The financings in this chart include only public offerings in the U.S. The data were compiled primarily from BioWorld Financial Watch's monthly financing charts covering the period from Jan. 1 to July 16, 2004. The gross proceed totals include money raised through overallotment options, when disclosed. | ||||||
Unless otherwise noted, shares are traded on the Nasdaq exchange. | ||||||
AMEX = American Stock Exchange. |